{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T19:02:32Z","timestamp":1775674952664,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020963","name":"Moonshot Research and Development Program","doi-asserted-by":"publisher","award":["21zf0127003h001"],"award-info":[{"award-number":["21zf0127003h001"]}],"id":[{"id":"10.13039\/501100020963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K07122"],"award-info":[{"award-number":["23K07122"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24H00492"],"award-info":[{"award-number":["24H00492"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nucmedbio.2025.109579","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:24:49Z","timestamp":1762388689000},"page":"109579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Estimation of the binding potential of the PET ligand [18F]FEDAC to translocator protein 18\u00a0kDa (TSPO) in the brain of experimental stroke model rats"],"prefix":"10.1016","volume":"150-151","author":[{"given":"Tomoteru","family":"Yamasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakana","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsushi","family":"Kumata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekatsu","family":"Wakizaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Arashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kurihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanao","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuki","family":"Nengaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109579_bb0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/cells9020512","article-title":"The translocator protein (TSPO) in mitochondrial bioenergetics and immune processes","volume":"9","author":"Betlazar","year":"2020","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.nucmedbio.2025.109579_bb0010","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.3390\/ijms20133161","article-title":"Recent developments in TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders","volume":"20","author":"Werry","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nucmedbio.2025.109579_bb0015","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jnc.13607","article-title":"Neuroinflammation: the devil is in the details","volume":"139 Suppl 2(Suppl 2)","author":"DiSabato","year":"2016","journal-title":"J Neurochem"},{"issue":"5726","key":"10.1016\/j.nucmedbio.2025.109579_bb0020","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109579_bb0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-1-14","article-title":"Microglia and neuroinflammation: a pathological perspective","volume":"1","author":"Streit","year":"2004","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.nucmedbio.2025.109579_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-9658-2_3","article-title":"Physiology of microglia","volume":"2034","author":"Garaschuk","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.nucmedbio.2025.109579_bb0035","doi-asserted-by":"crossref","first-page":"45s","DOI":"10.2967\/jnumed.121.263200","article-title":"Imaging neuroinflammation in neurodegenerative disorders","volume":"63","author":"Masdeu","year":"2022","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.nucmedbio.2025.109579_bb0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11910-019-0951-x","article-title":"PET evaluation of microglial activation in non-neurodegenerative brain diseases","volume":"19","author":"Ghadery","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"10.1016\/j.nucmedbio.2025.109579_bb0045","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.73.3.476","article-title":"Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography","volume":"73","author":"Charbonneau","year":"1986","journal-title":"Circulation"},{"issue":"28","key":"10.1016\/j.nucmedbio.2025.109579_bb0050","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.2174\/0929867329666220329204054","article-title":"Essential principles and recent progress in the development of TSPO PET ligands for neuroinflammation imaging","volume":"29","author":"Viviano","year":"2022","journal-title":"Curr Med Chem"},{"issue":"11","key":"10.1016\/j.nucmedbio.2025.109579_bb0055","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.2967\/jnumed.107.043505","article-title":"11C-AC-5216: a novel PET ligand for peripheral benzodiazepine receptors in the primate brain","volume":"48","author":"Zhang","year":"2007","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.nucmedbio.2025.109579_bb0060","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2967\/jnumed.109.062554","article-title":"Quantitative analysis of peripheral benzodiazepine receptor in the human brain using PET with (11)C-AC-5216","volume":"50","author":"Miyoshi","year":"2009","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.nucmedbio.2025.109579_bb0065","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2967\/jnumed.109.072223","article-title":"18F-FEAC and 18F-FEDAC: PET of the monkey brain and imaging of translocator protein (18 kDa) in the infarcted rat brain","volume":"51","author":"Yui","year":"2010","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109579_bb0070","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bmcl.2009.01.093","article-title":"[18F]FEAC and [18F]FEDAC: two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain","volume":"19","author":"Yanamoto","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"10.1016\/j.nucmedbio.2025.109579_bb0075","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s12149-021-01630-7","article-title":"[(18)F]FEDAC translocator protein positron emission tomography-computed tomography for early detection of mitochondrial dysfunction secondary to myocardial ischemia","volume":"35","author":"Luo","year":"2021","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109579_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2021.10.003","article-title":"Translocator protein imaging with (18)F-FEDAC-positron emission tomography in rabbit atherosclerosis and its presence in human coronary vulnerable plaques","volume":"337","author":"Maekawa","year":"2021","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.nucmedbio.2025.109579_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045065","article-title":"PET imaging of lung inflammation with [18F]FEDAC, a radioligand for translocator protein (18 kDa)","volume":"7","author":"Hatori","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109579_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086625","article-title":"Visualization of acute liver damage induced by cycloheximide in rats using PET with [(18)F]FEDAC, a radiotracer for translocator protein (18 kDa)","volume":"9","author":"Hatori","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.nucmedbio.2025.109579_bb0095","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jhep.2012.07.002","article-title":"Translocator protein (18 kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease","volume":"57","author":"Xie","year":"2012","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.nucmedbio.2025.109579_bb0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12149-023-01895-0","article-title":"A first-in-man study of [(18)F] FEDAC: a novel PET tracer for the 18-kDa translocator protein","volume":"38","author":"Tamura","year":"2024","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109579_bb0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00259-021-05379-z","article-title":"TSPO imaging in animal models of brain diseases","volume":"49","author":"Van Camp","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2025.109579_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.02.076","article-title":"Evaluation of the novel TSPO radiotracer 2-(7-butyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)-5-methylpyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide in a preclinical model of neuroinflammation","volume":"150","author":"Tang","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"9","key":"10.1016\/j.nucmedbio.2025.109579_bb0115","doi-asserted-by":"crossref","first-page":"961","DOI":"10.7150\/thno.12027","article-title":"[18F]FEBMP: positron emission tomography imaging of TSPO in a model of neuroinflammation in rats, and in vitro autoradiograms of the human brain","volume":"5","author":"Tiwari","year":"2015","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109579_bb0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuroimage.2010.08.010","article-title":"Visualization of early infarction in rat brain after ischemia using a translocator protein (18 kDa) PET ligand [11C]DAC with ultra-high specific activity","volume":"54","author":"Yui","year":"2011","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109579_bb0125","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s00259-022-06057-4","article-title":"Non-invasive kinetic modelling approaches for quantitative analysis of brain PET studies","volume":"50","author":"van der Weijden","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.nucmedbio.2025.109579_bb0130","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/STROKEAHA.122.036946","article-title":"Neuroinflammation, stroke, blood-brain barrier dysfunction, and imaging modalities","volume":"53","author":"Candelario-Jalil","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.nucmedbio.2025.109579_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.apradiso.2020.109571","article-title":"Radiosynthesis of (18)F-fluoroethylated tracers via a simplified one-pot (18)F-fluoroethylation method using [(18)F]fluoroethyl tosylate","volume":"169","author":"Kawamura","year":"2021","journal-title":"Appl Radiat Isot"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109579_bb0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109579_bb0145","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1177\/0271678X231152025","article-title":"Small-animal PET study for noninvasive quantification of transmembrane AMPA receptor regulatory protein \u03b3-8 (TARP \u03b3-8) in the brain","volume":"43","author":"Yamasaki","year":"2023","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109579_bb0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0969-8043(00)00392-4","article-title":"Sensitive measurement of positron emitters eluted from HPLC","volume":"55","author":"Takei","year":"2001","journal-title":"Appl Radiat Isot"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109579_bb0155","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/syn.20761","article-title":"Imaging of the translocator protein (18 kDa) in rat brain after ischemia using [11C]DAC with ultra-high specific activity","volume":"64","author":"Yui","year":"2010","journal-title":"Synapse"},{"issue":"10","key":"10.1016\/j.nucmedbio.2025.109579_bb0160","first-page":"1836","article-title":"SUV: standard uptake or silly useless value?","volume":"36","author":"Keyes","year":"1995","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.nucmedbio.2025.109579_bb0165","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2967\/jnumed.112.105908","article-title":"In vivo measurement of the affinity and density of metabotropic glutamate receptor subtype 1 in rat brain using 18F-FITM in small-animal PET","volume":"53","author":"Yamasaki","year":"2012","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.nucmedbio.2025.109579_bb0170","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/jcbfm.1991.130","article-title":"Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography","volume":"11","author":"Koeppe","year":"1991","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"10.1016\/j.nucmedbio.2025.109579_bb0175","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3 Pt 1","key":"10.1016\/j.nucmedbio.2025.109579_bb0180","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"issue":"47","key":"10.1016\/j.nucmedbio.2025.109579_bb0185","doi-asserted-by":"crossref","first-page":"12255","DOI":"10.1523\/JNEUROSCI.2312-08.2008","article-title":"Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer\u2019s and other CNS pathologies","volume":"28","author":"Ji","year":"2008","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.nucmedbio.2025.109579_bb0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.apsb.2020.08.006","article-title":"Recent developments on PET radiotracers for TSPO and their applications in neuroimaging","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"10.1016\/j.nucmedbio.2025.109579_bb0195","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.7150\/thno.15616","article-title":"PET imaging with [(18)F]FSPG evidences the role of system xc(-) on brain inflammation following cerebral ischemia in rats","volume":"6","author":"Domercq","year":"2016","journal-title":"Theranostics"},{"issue":"19","key":"10.1016\/j.nucmedbio.2025.109579_bb0200","doi-asserted-by":"crossref","first-page":"9492","DOI":"10.7150\/thno.64320","article-title":"Neuroprotective effects of minocycline and KML29, a potent inhibitor of monoacylglycerol lipase, in an experimental stroke model: a small-animal positron emission tomography study","volume":"11","author":"Yamasaki","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109579_bb0205","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13550-018-0392-6","article-title":"[(18)F]DPA-714 PET imaging shows immunomodulatory effect of intravenous administration of bone marrow stromal cells after transient focal ischemia","volume":"8","author":"Tan","year":"2018","journal-title":"EJNMMI Res"},{"issue":"6","key":"10.1016\/j.nucmedbio.2025.109579_bb0210","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3390\/cells10061350","article-title":"TSPO expression modulatory effect of acetylcholinesterase inhibitor in the ischemic stroke rat model","volume":"10","author":"Song","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109579_bb0215","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","article-title":"Dual microglia effects on blood brain barrier permeability induced by systemic inflammation","volume":"10","author":"Haruwaka","year":"2019","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.nucmedbio.2025.109579_bb0220","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1177\/0271678X16680221","article-title":"Temporal analysis of blood-brain barrier disruption and cerebrospinal fluid matrix metalloproteinases in rhesus monkeys subjected to transient ischemic stroke","volume":"37","author":"Zhang","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"10.1016\/j.nucmedbio.2025.109579_bb0225","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.3390\/ijms19092707","article-title":"Cellular sources and regional variations in the expression of the neuroinflammatory marker translocator protein (TSPO) in the normal brain","volume":"19","author":"Betlazar","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.nucmedbio.2025.109579_bb0230","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00259-020-05166-2","article-title":"Cellular sources of TSPO expression in healthy and diseased brain","volume":"49","author":"Nutma","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.nucmedbio.2025.109579_bb0235","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.neuroimage.2009.05.099","article-title":"Quantitative evaluation of changes in binding potential with a simplified reference tissue model and multiple injections of [11C]raclopride","volume":"47","author":"Ikoma","year":"2009","journal-title":"Neuroimage"},{"issue":"7","key":"10.1016\/j.nucmedbio.2025.109579_bb0240","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2967\/jnumed.111.101626","article-title":"Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I","volume":"53","author":"Sasaki","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2025.109579_bb0245","article-title":"Potential for in vivo visualization of intracellular pH gradient in the brain using PET imaging","volume":"6(3):fcae172","author":"Yamasaki","year":"2024","journal-title":"Brain Commun"},{"issue":"5","key":"10.1016\/j.nucmedbio.2025.109579_bb0250","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.14336\/AD.2022.0225","article-title":"P-glycoprotein aggravates blood brain barrier dysfunction in experimental ischemic stroke by inhibiting endothelial autophagy","volume":"13","author":"Huang","year":"2022","journal-title":"Aging Dis"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125005888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805125005888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:46:35Z","timestamp":1773877595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805125005888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"alternative-id":["S0969805125005888"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109579","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimation of the binding potential of the PET ligand [18F]FEDAC to translocator protein 18\u00a0kDa (TSPO) in the brain of experimental stroke model rats","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2025.109579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109579"}}